\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ vitals\\ wnl\ \(0\)\
\-\ cardio\\,\\ pulm\\,\\ abdominal\\ exam\\ were\\ all\\ unremarkable\\.\ \(0\)\
\-\ l\\ fifth\\ digit\\ swollen\\.\\ non\\ tender\\ to\\ palpation\\,\\ but\\ range\\ of\\ motion\\ limited\\ secondary\\ to\\ swollen\\ size\\.\\ non\\ erythematous\\.\\ no\\ overlying\\ skin\\ changes\\.\\ sensation\\ intact\\.\\ radial\\ pulse\\ palpable\\.\ \(0\)\
\-\ enchondromas\\ are\\ treated\\ expectantly\\,\\ and\\ may\\ be\\ followed\\ serially\\ to\\ rule\\ out\\ aggressive\\ transformation\\ \\(2\\,3\\,7\\)\\.\\ pathologic\\ fractures\\ are\\ often\\ treated\\ non\\-operatively\\,\\ with\\ immobilization\\ \\(2\\,3\\)\\.\\ surgical\\ management\\ may\\ be\\ explored\\ if\\ there\\ is\\ concern\\ for\\ future\\ fractures\\,\\ symptomatic\\ findings\\,\\ and\\/or\\ fear\\ of\\ malignancy\\.\\ curettage\\ with\\ or\\ without\\ bone\\ grafting\\,\\ followed\\ by\\ immobilization\\,\\ physical\\ therapy\\,\\ and\\ serial\\ radiographs\\ \\(at\\ the\\ 3\\,5\\,\\ and\\ 12\\ month\\ mark\\ in\\ both\\ operative\\ and\\ non\\-operative\\ patients\\)\\ may\\ be\\ done\\ in\\ these\\ settings\\ \\(2\\,3\\,7\\)\\.\\ therapies\\ like\\ high\\ speed\\ burring\\ or\\ alcohol\\ instillation\\ are\\ not\\ recommended\\ \\(7\\)\\.\ \(0\)\
\-\ fracture\\ through\\ the\\ 5th\\ proximal\\ phalanx\\.\\ \\ underlying\\ lytic\\ lesion\\ with\\ bone\\ expansion\\ and\\ endosteal\\ scalloping\ \(0\)\
\-\ enchondroma\ \(73\)\
\-\ enchondroma\ \(73\)\
\-\ bone\\ infarct\\ \\(but\\ no\\ pain\\/\\ known\\ mechanism\\ or\\ risk\\ factor\\)\ \(0\)\
\-\ chondrosarcoma\\ \\(no\\ pain\\,\\ swelling\\;\\ no\\ aggressive\\ growth\\)\ \(0\)\
\-\ infection\\ \\(no\\ systemic\\ symptoms\\ or\\ mechanism\\ for\\ infection\\)\ \(0\)\
\-\ hpi\\:\\ \ \(0\)\
\-\ a\\ 26yo\\ active\\ duty\\ man\\ presents\\ to\\ his\\ battalion\\ medical\\ officer\\ following\\ an\\ injury\\ during\\ combatives\\ training\\.\\ he\\ states\\ that\\ his\\ finger\\ was\\ caught\\ between\\ his\\ opponent\\?s\\ helmet\\ and\\ the\\ ground\\.\\ it\\ was\\ initially\\ painful\\ and\\ swollen\\,\\ but\\ the\\ pain\\ has\\ since\\ subsided\\.\\ he\\ has\\ no\\ previous\\ injuries\\ to\\ his\\ finger\\ and\\ other\\ symptoms\\.\\ \\ \ \(0\)\
\-\ to\\ rule\\ out\\ a\\ fracture\\,\\ a\\ hand\\ x\\-ray\\ was\\ obtained\\.\\ the\\ following\\ image\\ was\\ noted\\.\ \(0\)\
\-\ he\\ presents\\ to\\ your\\ clinic\\ for\\ work\\ up\\ of\\ hand\\ finding\\.\ \(0\)\
\-\ pmh\\:\\ unremarkable\ \(0\)\
\-\ psh\\:\\ r\\ inguinal\\ hernia\\ repair\ \(0\)\
\-\ meds\\:\\ multi\\-vitamins\\;\\ pre\\-workout\ \(0\)\
\-\ fam\\ history\\:\\ breast\\ cancer\\ in\\ mother\\;\\ prostate\\ cancer\\ in\\ grand\\ father\ \(0\)\
\-\ these\\ benign\\,\\ osteolytic\\ tumors\\ appear\\ as\\ \\"well\\ defined\\ areas\\ of\\ central\\ lucency\\ in\\ the\\ metaphyseal\\ or\\ diaphyseal\\ portion\\ of\\ the\\ bone\\ \\(1\\)\\.\\"\\ other\\ findings\\ associated\\ with\\ enchondromas\\ include\\ endosteal\\ scalloping\\,\\ thinning\\,\\ stippling\\,\\ and\\ punctate\\ calcifications\\ \\(2\\,3\\)\\.\\ of\\ note\\,\\ larger\\ lesions\\-specifically\\ those\\ in\\ the\\ hand\\-\\ tend\\ to\\ occur\\ further\\ away\\ from\\ the\\ growth\\ plate\\ possibly\\ due\\ to\\ \\?earlier\\ development\\ and\\ migration\\(2\\)\\.\\?\ \(0\)\
\-\ enchondromas\\ are\\ benign\\ intramedullary\\ bone\\ tumors\\ that\\ are\\ believed\\ to\\ arise\\ from\\ cartilaginous\\ fragments\\ near\\ the\\ central\\ physis\\ \\(3\\)\\.\\ other\\ theories\\ with\\ respect\\ to\\ their\\ development\\ include\\ jaffe\\?s\\ hypothesis\\ which\\ postulates\\ that\\ embryonic\\ cartilaginous\\ cells\\ from\\ the\\ epiphyseal\\ plate\\ are\\ displaced\\ during\\ normal\\ growth\\,\\ continue\\ to\\ develop\\,\\ and\\ become\\ enchondromas\\ in\\ the\\ area\\ in\\ which\\ they\\ settle\\ \\(1\\)\\.\\ molecular\\ studies\\ have\\ shown\\ that\\ there\\ is\\ some\\ association\\ with\\ the\\ genes\\ idh1\\ and\\ idh2\\ \\(1\\,\\ 4\\)\\.\\ \ \(0\)\
\-\ epidemiologically\\,\\ enchondromas\\ are\\ the\\ second\\ most\\ common\\ benign\\ bone\\ tumor\\ found\\ in\\ children\\/adolescents\\ \\(with\\ osteochondromas\\ leading\\ the\\ way\\)\\,\\ accounting\\ for\\ up\\ to\\ 24\\%\\ of\\ such\\ tumors\\ \\(1\\)\\.\\ they\\ occur\\ equally\\ in\\ men\\ and\\ women\\;\\ and\\ account\\ for\\ 12\\%\\-14\\%\\ of\\ benign\\ bone\\ tumors\\ and\\ 3\\%\\-10\\%\\ of\\ all\\ bone\\ tumors\\ in\\ the\\ general\\ population\\ \\(3\\)\\.\\ studies\\ have\\ shown\\ that\\ 35\\%\\ of\\ enchondromas\\ arise\\ in\\ the\\ hand\\,\\ with\\ 50\\%\\ of\\ these\\ arising\\ in\\ the\\ proximal\\ phalanx\\ \\(as\\ in\\ our\\ patient\\)\\.\\ enchondromas\\ typically\\ arise\\ in\\ the\\ hands\\ and\\ feet\\,\\ but\\ have\\ also\\ been\\ reported\\ in\\ the\\ femur\\,\\ tibiam\\,\\ calcaneus\\,\\ and\\ atlas\\ \\(1\\,4\\,5\\)\\.\ \(0\)\
\-\ clinical\\ presentation\\ and\\ malignant\\ transformation\\:\ \(0\)\
\-\ these\\ benign\\ tumors\\ are\\ usually\\ asymptomatic\\ and\\ found\\ incidentally\\ on\\ radiographic\\ examination\\ \\(1\\,2\\,3\\,5\\)\\.\\ on\\ occasion\\,\\ the\\ bone\\ loss\\ can\\ lead\\ to\\ pathologic\\ fractures\\ \\(2\\)\\.\\ pain\\ and\\ aggressive\\ progression\\ are\\ atypical\\ and\\ warrants\\ close\\ monitoring\\/\\ further\\ work\\ up\\.\\ though\\ malignant\\ transformation\\ of\\ solitary\\ enchondromas\\ is\\ exceedingly\\ rare\\ \\(1\\)\\,\\ two\\ syndromes\\ should\\ that\\ should\\ be\\ kept\\ in\\ mind\\ are\\ ollier\\ disease\\ \\(multiple\\ enchondromas\\ in\\ several\\ bones\\)\\ and\\ maffucci\\ syndrome\\ \\(multiple\\ enchondromas\\ and\\ hemangiomas\\)\\ \\(6\\)\\.\\ these\\ two\\ diseases\\/syndromes\\ have\\ been\\ associated\\ with\\ higher\\ malignant\\ transformation\\ rates\\ to\\ chondrosarcoma\\,\\ and\\ in\\ maffucci\\ syndrome\\,\\ non\\-skeletal\\ tumors\\ like\\ astrocytomas\\ and\\ granulosa\\-cell\\ ovarian\\ tumor\\ \\(6\\)\\.\ \(0\)\
\-\ histologic\\ findings\\:\ \(0\)\
\-\ enchondromas\\ can\\ be\\ confirmed\\ via\\ histology\\.\\ they\\ are\\ associated\\ with\\ lobulated\\ cartilaginous\\ tissue\\ with\\ \\?banal\\-appearing\\ chondrocytes\\ arranged\\ in\\ clustered\\ lacunae\\ with\\ a\\ background\\ of\\ abundant\\ hyaline\\ cartilage\\ matrix\\ \\(1\\)\\.\\?\\ chondrocytes\\ nuclei\\ are\\ of\\ different\\ sizes\\ and\\ may\\ be\\ binucleate\\.\\ these\\ may\\ be\\ hypo\\-\\ or\\ hypercellular\\,\\ but\\ are\\ not\\ associated\\ with\\ mitoses\\.\\ \ \(0\)\
\-\ resources\\:\ \(0\)\
\-\ 1\\)\\	bierry\\ et\\ al\\.\\ \\?enchondromas\\ in\\ children\\:\\ imaging\\ appearance\\ with\\ pathological\\ correlation\\.\\?\\ skeletal\\ radiology\\.\\ vol\\ 41\\.\\ 1223\\-1229\\.\\ 2010\ \(0\)\
\-\ 2\\)\\	jacobson\\,\\ m\\.\\ and\\ ruff\\,\\ m\\.\\ \\?solitary\\ enchondroma\\ of\\ the\\ phalanx\\.\\?\\ journal\\ of\\ hand\\ surgery\\.\\ vol\\ 36\\.\\ 1845\\-1847\\.\\ 2011\ \(0\)\
\-\ 3\\)\\	reisler\\ et\\ al\\.\\ \\?osseous\\ tumor\\ of\\ the\\ hand\\:\\ finger\\ enchondroma\\.\\?\\ eplasty\\-\\ interesting\\ case\\ series\\.\\ vol\\ \\ 15\\.\\ \\ 2015\\.\ \(0\)\
\-\ 4\\)\\	wani\\ et\\ al\\.\\ \\?isolated\\ enchondroma\\ of\\ atlas\\.\\?\\ turkish\\ neurosurgery\\.\\ vol\\ 21\\ issue\\ 2\\.\\ 2011\ \(0\)\
\-\ 5\\)\\	\\ komurcu\\ et\\ al\\.\\ \\?atypical\\ localization\\ of\\ enchondroma\\ in\\ the\\ calcaneus\\.\\?\\ journal\\ of\\ the\\ american\\ podiatric\\ medical\\ association\\.\\ vol\\ 105\\ issue\\ 3\\.\\ 2015\ \(0\)\
\-\ 6\\)\\	schwartz\\ et\\ al\\.\\ \\?the\\ malignant\\ potential\\ of\\ enchoromatosis\\.\\?\\ the\\ journal\\ of\\ bone\\ and\\ joint\\ surgery\\.\\ vol\\ 69\\ issue\\ 2\\.\\ 1987\\.\ \(0\)\
\-\ 7\\)\\	tang\\ et\\ al\\.\\ \\?current\\ management\\ of\\ hand\\ enchondroma\\:\\ a\\ review\\.\\?\\ hand\\ surgery\\.\\ vol\\ 20\\.\\ 2015\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ enchondromas\\:\\ 0\\.07433778869976168\ \(0\)\
\-\ \\?\\:\\ 0\\.0661026660183252\ \(0\)\
\-\ vol\\:\\ 0\\.03971390663454636\ \(0\)\
\-\ enchondroma\\:\\ 0\\.035227890624164426\ \(0\)\
\-\ hand\\:\\ 0\\.024366198821954368\ \(0\)\
\-\ \\)\\:\\ 0\\.024043886552876485\ \(0\)\
\-\ tumors\\:\\ 0\\.022267606049250255\ \(0\)\
\-\ al\\:\\ 0\\.021541495974685555\ \(0\)\
\-\ bone\\:\\ 0\\.02104494233359633\ \(0\)\
\-\ et\\:\\ 0\\.020797215639973925\ \(0\)\
\-\ \\(\\:\\ 0\\.01932979842277922\ \(0\)\
\-\ transformation\\:\\ 0\\.019208033738015367\ \(0\)\
\-\ issue\\:\\ 0\\.0176168880061556\ \(0\)\
\-\ 2\\,3\\,7\\:\\ 0\\.017473772891905843\ \(0\)\
\-\ 2015\\:\\ 0\\.017020245700519868\ \(0\)\
\-\ cartilaginous\\:\\ 0\\.016303212825940418\ \(0\)\
\-\ chondrocytes\\:\\ 0\\.015296146948064198\ \(0\)\
\-\ are\\:\\ 0\\.015008285770946305\ \(0\)\
\-\ benign\\:\\ 0\\.014613728280640245\ \(0\)\
\-\ journal\\:\\ 0\\.014406025303511526\ \(0\)\
\-\ maffucci\\:\\ 0\\.01428360854614945\ \(0\)\
\-\ phalanx\\:\\ 0\\.014137984380832743\ \(0\)\
\-\ 1\\:\\ 0\\.01410632762707428\ \(0\)\
\-\ atlas\\:\\ 0\\.013922217947945377\ \(0\)\
\-\ \\%\\:\\ 0\\.013828788140160607\ \(0\)\
\-\ swollen\\:\\ 0\\.013536685471531763\ \(0\)\
\-\ finger\\:\\ 0\\.013454090137219347\ \(0\)\
\-\ \\:\\:\\ 0\\.013442316939433083\ \(0\)\
\-\ 2\\,3\\:\\ 0\\.01335198589154938\ \(0\)\
\-\ these\\:\\ 0\\.013224051686567928\ \(0\)\
\-\ arise\\:\\ 0\\.012578446814556768\ \(0\)\
\-\ aggressive\\:\\ 0\\.012430493862448551\ \(0\)\
\-\ malignant\\:\\ 0\\.012244482364239053\ \(0\)\
\-\ growth\\:\\ 0\\.011047528234318036\ \(0\)\
\-\ endosteal\\:\\ 0\\.010868808550626946\ \(0\)\
\-\ calcaneus\\:\\ 0\\.010868808550626946\ \(0\)\
\-\ 2011\\:\\ 0\\.010732053602188985\ \(0\)\
\-\ scalloping\\:\\ 0\\.010426502205108195\ \(0\)\
\-\ 3\\:\\ 0\\.009915636901419918\ \(0\)\
\-\ his\\:\\ 0\\.009763682963912515\ \(0\)\
\-\ \\,\\:\\ 0\\.009658634646801134\ \(0\)\
\-\ fractures\\:\\ 0\\.009620778784876934\ \(0\)\
\-\ may\\:\\ 0\\.009288049399891595\ \(0\)\
\-\ in\\:\\ 0\\.009188046643295944\ \(0\)\
\-\ they\\:\\ 0\\.009154448344362654\ \(0\)\
\-\ be\\:\\ 0\\.0091420188933672\ \(0\)\
\-\ 2\\:\\ 0\\.009118456375176146\ \(0\)\
\-\ immobilization\\:\\ 0\\.009110031157166286\ \(0\)\
\-\ but\\:\\ 0\\.0090312353866875\ \(0\)\
\-\ that\\:\\ 0\\.008776892340290327\ \(0\)\
\-\ 3\\,5\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ burring\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ pain\\/\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ 26yo\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ combatives\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ multi\\-vitamins\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ pre\\-workout\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ grand\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ stippling\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ lesions\\-specifically\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ hand\\-\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ jaffe\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ postulates\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ idh2\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ epidemiologically\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ children\\/adolescents\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ \\-14\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ tibiam\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ 1\\,4\\,5\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ monitoring\\/\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ diseases\\/syndromes\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ non\\-skeletal\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ granulosa\\-cell\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ banal\\-appearing\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ bierry\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ 1223\\-1229\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ ruff\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ 1845\\-1847\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ reisler\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ eplasty\\-\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ wani\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ komurcu\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ enchoromatosis\\:\\ 0\\.008736886445952921\ \(0\)\
\-\ mechanism\\:\\ 0\\.008714921340277303\ \(0\)\
\-\ plate\\:\\ 0\\.008489432964942006\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.008468233184730415\ \(0\)\
\-\ solitary\\:\\ 0\\.008405961239768316\ \(0\)\
\-\ association\\:\\ 0\\.008230087868888862\ \(0\)\
\-\ expectantly\\:\\ 0\\.008049921945893511\ \(0\)\
\-\ 1\\,2\\,3\\,5\\:\\ 0\\.008049921945893511\ \(0\)\
\-\ binucleate\\:\\ 0\\.008049921945893511\ \(0\)\
\-\ podiatric\\:\\ 0\\.008049921945893511\ \(0\)\
\-\ tang\\:\\ 0\\.008049921945893511\ \(0\)\
\-\ \\;\\:\\ 0\\.008029419974043979\ \(0\)\
\-\ associated\\:\\ 0\\.00799390510171537\ \(0\)\
\-\ work\\:\\ 0\\.007935250879274689\ \(0\)\
\-\ like\\:\\ 0\\.007840844439256344\ \(0\)\
\-\ serially\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ battalion\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ opponent\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ settle\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ idh1\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ hypercellular\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ schwartz\\:\\ 0\\.007648073474032099\ \(0\)\
\-\ 6\\:\\ 0\\.007588067873265236\ \(0\)\
\-\ pathologic\\:\\ 0\\.007413963545555344\ \(0\)\
\-\ development\\:\\ 0\\.0073771421668181085\ \(0\)\
\-\ helmet\\:\\ 0\\.0073629574458341\ \(0\)\
\-\ \\-10\\:\\ 0\\.0073629574458341\ \(0\)\
\-\ lacunae\\:\\ 0\\.0073629574458341\ \(0\)\
\-\ jacobson\\:\\ 0\\.0073629574458341\ \(0\)\
\-\ atypical\\:\\ 0\\.007340992340158484\ \(0\)\
\-\ have\\:\\ 0\\.007335730736828906\ \(0\)\
\-\ cardio\\:\\ 0\\.007141804273074725\ \(0\)\
\-\ fear\\:\\ 0\\.007141804273074725\ \(0\)\
\-\ instillation\\:\\ 0\\.007141804273074725\ \(0\)\
\-\ turkish\\:\\ 0\\.007141804273074725\ \(0\)\
\-\ he\\:\\ 0\\.007088763157679939\ \(0\)\
\-\ rule\\:\\ 0\\.0070733287449078535\ \(0\)\
\-\ non\\:\\ 0\\.007001614856746303\ \(0\)\
\-\ subsided\\:\\ 0\\.006961108973972689\ \(0\)\
\-\ warrants\\:\\ 0\\.006961108973972689\ \(0\)\
\-\ exceedingly\\:\\ 0\\.006961108973972689\ \(0\)\
\-\ hypo\\-\\:\\ 0\\.006961108973972689\ \(0\)\
\-\ mitoses\\:\\ 0\\.006961108973972689\ \(0\)\
\-\ 12\\:\\ 0\\.006932405213324642\ \(0\)\
\-\ up\\:\\ 0\\.006832052976375292\ \(0\)\
\-\ explored\\:\\ 0\\.006808333275432294\ \(0\)\
\-\ theories\\:\\ 0\\.006808333275432294\ \(0\)\
\-\ genes\\:\\ 0\\.006808333275432294\ \(0\)\
\-\ resources\\:\\ 0\\.006808333275432294\ \(0\)\
\-\ shown\\:\\ 0\\.006791767480971253\ \(0\)\
\-\ mark\\:\\ 0\\.00667599294577469\ \(0\)\
\-\ officer\\:\\ 0\\.00667599294577469\ \(0\)\
\-\ fam\\:\\ 0\\.00667599294577469\ \(0\)\
\-\ clustered\\:\\ 0\\.00667599294577469\ \(0\)\
\-\ hpi\\:\\ 0\\.006559260502111277\ \(0\)\
\-\ caught\\:\\ 0\\.006559260502111277\ \(0\)\
\-\ 1987\\:\\ 0\\.006559260502111277\ \(0\)\
\-\ 7\\:\\ 0\\.006490098867805891\ \(0\)\
\-\ non\\-operatively\\:\\ 0\\.0064548397730153145\ \(0\)\
\-\ hypothesis\\:\\ 0\\.0064548397730153145\ \(0\)\
\-\ embryonic\\:\\ 0\\.0064548397730153145\ \(0\)\
\-\ molecular\\:\\ 0\\.0064548397730153145\ \(0\)\
\-\ occasion\\:\\ 0\\.0064548397730153145\ \(0\)\
\-\ abundant\\:\\ 0\\.0064548397730153145\ \(0\)\
\-\ management\\:\\ 0\\.006391539035590964\ \(0\)\
\-\ occur\\:\\ 0\\.00635489916507738\ \(0\)\
\-\ to\\:\\ 0\\.006348881691421996\ \(0\)\
\-\ studies\\:\\ 0\\.006326067230483964\ \(0\)\
\-\ settings\\:\\ 0\\.006274144473913278\ \(0\)\
\-\ ollier\\:\\ 0\\.0061948157249801395\ \(0\)\
\-\ surgery\\:\\ 0\\.006169471945570689\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.006121368775372883\ \(0\)\
\-\ osteochondromas\\:\\ 0\\.006121368775372883\ \(0\)\
\-\ mind\\:\\ 0\\.006121368775372883\ \(0\)\
\-\ hyaline\\:\\ 0\\.006052991301153903\ \(0\)\
\-\ psh\\:\\ 0\\.005989028445715279\ \(0\)\
\-\ arranged\\:\\ 0\\.005989028445715279\ \(0\)\
\-\ or\\:\\ 0\\.005955536663807973\ \(0\)\
\-\ kept\\:\\ 0\\.005928944578701964\ \(0\)\
\-\ tumor\\:\\ 0\\.005923386426989528\ \(0\)\
\-\ non\\-operative\\:\\ 0\\.005872296002051867\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.005872296002051867\ \(0\)\
\-\ other\\:\\ 0\\.0058562097582828005\ \(0\)\
\-\ speed\\:\\ 0\\.005767875272955904\ \(0\)\
\-\ accounting\\:\\ 0\\.005767875272955904\ \(0\)\
\-\ 105\\:\\ 0\\.005767875272955904\ \(0\)\
\-\ osteolytic\\:\\ 0\\.005719520303511472\ \(0\)\
\-\ followed\\:\\ 0\\.005678643947232451\ \(0\)\
\-\ therapies\\:\\ 0\\.005673415233506622\ \(0\)\
\-\ your\\:\\ 0\\.005673415233506622\ \(0\)\
\-\ pulm\\:\\ 0\\.005629359968322446\ \(0\)\
\-\ grafting\\:\\ 0\\.005629359968322446\ \(0\)\
\-\ equally\\:\\ 0\\.005629359968322446\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0056076638626007145\ \(0\)\
\-\ out\\:\\ 0\\.005597728199917772\ \(0\)\
\-\ central\\:\\ 0\\.005573104770782872\ \(0\)\
\-\ cancer\\:\\ 0\\.005568216579513906\ \(0\)\
\-\ background\\:\\ 0\\.005546722100196529\ \(0\)\
\-\ sizes\\:\\ 0\\.005546722100196529\ \(0\)\
\-\ localization\\:\\ 0\\.005507851224920729\ \(0\)\
\-\ findings\\:\\ 0\\.005407840245163408\ \(0\)\
\-\ should\\:\\ 0\\.005399818715339544\ \(0\)\
\-\ training\\:\\ 0\\.00539962596033699\ \(0\)\
\-\ respect\\:\\ 0\\.00539962596033699\ \(0\)\
\-\ further\\:\\ 0\\.005386410588305765\ \(0\)\
\-\ histologic\\:\\ 0\\.005366026801094492\ \(0\)\
\-\ found\\:\\ 0\\.00533800914658496\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.005333529454391825\ \(0\)\
\-\ 69\\:\\ 0\\.005333529454391825\ \(0\)\
\-\ nuclei\\:\\ 0\\.005302063945655869\ \(0\)\
\-\ curettage\\:\\ 0\\.0052715667616452105\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.0052715667616452105\ \(0\)\
\-\ digit\\:\\ 0\\.005241980078642554\ \(0\)\
\-\ intramedullary\\:\\ 0\\.005241980078642554\ \(0\)\
\-\ 2010\\:\\ 0\\.005241980078642554\ \(0\)\
\-\ meds\\:\\ 0\\.0052132511025540975\ \(0\)\
\-\ medical\\:\\ 0\\.0052117141725787994\ \(0\)\
\-\ during\\:\\ 0\\.005183368186172067\ \(0\)\
\-\ no\\:\\ 0\\.005116615365929447\ \(0\)\
\-\ physis\\:\\ 0\\.005106002753059318\ \(0\)\
\-\ proximal\\:\\ 0\\.005085318496941556\ \(0\)\
\-\ believed\\:\\ 0\\.0050809107728964934\ \(0\)\
\-\ treated\\:\\ 0\\.005070071032871872\ \(0\)\
\-\ father\\:\\ 0\\.005056438411558167\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.005056438411558167\ \(0\)\
\-\ thinning\\:\\ 0\\.005032555803452061\ \(0\)\
\-\ histology\\:\\ 0\\.005032555803452061\ \(0\)\
\-\ migration\\:\\ 0\\.0050092351915489945\ \(0\)\
\-\ interesting\\:\\ 0\\.0050092351915489945\ \(0\)\
\-\ and\\:\\ 0\\.0049952945099129\ \(0\)\
\-\ way\\:\\ 0\\.0049641783292330805\ \(0\)\
\-\ m\\.\\:\\ 0\\.0049641783292330805\ \(0\)\
\-\ punctate\\:\\ 0\\.004942395468263036\ \(0\)\
\-\ pathological\\:\\ 0\\.004942395468263036\ \(0\)\
\-\ infection\\:\\ 0\\.004923719671105663\ \(0\)\
\-\ erythematous\\:\\ 0\\.004921081092424618\ \(0\)\
\-\ away\\:\\ 0\\.004921081092424618\ \(0\)\
\-\ rates\\:\\ 0\\.004921081092424618\ \(0\)\
\-\ s\\:\\ 0\\.004857814999236049\ \(0\)\
\-\ two\\:\\ 0\\.004851003444233906\ \(0\)\
\-\ syndrome\\:\\ 0\\.004844215216520597\ \(0\)\
\-\ syndromes\\:\\ 0\\.004840131606781142\ \(0\)\
\-\ following\\:\\ 0\\.004807289904660354\ \(0\)\
\-\ tend\\:\\ 0\\.004802008434503842\ \(0\)\
\-\ all\\:\\ 0\\.0047907304052156405\ \(0\)\
\-\ men\\:\\ 0\\.004783483030131044\ \(0\)\
\-\ account\\:\\ 0\\.004783483030131044\ \(0\)\
\-\ inguinal\\:\\ 0\\.004765297560687836\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.004765297560687836\ \(0\)\
\-\ include\\:\\ 0\\.004751543088266178\ \(0\)\
\-\ matrix\\:\\ 0\\.004729898073470712\ \(0\)\
\-\ 4\\:\\ 0\\.0047194685930209024\ \(0\)\
\-\ future\\:\\ 0\\.004695719504520098\ \(0\)\
\-\ ground\\:\\ 0\\.0046626804358703535\ \(0\)\
\-\ correlation\\:\\ 0\\.0046626804358703535\ \(0\)\
\-\ fifth\\:\\ 0\\.004646564954332415\ \(0\)\
\-\ been\\:\\ 0\\.0046081167283726285\ \(0\)\
\-\ operative\\:\\ 0\\.004569698517914304\ \(0\)\
\-\ continue\\:\\ 0\\.004569698517914304\ \(0\)\
\-\ 41\\:\\ 0\\.004512228490510587\ \(0\)\
\-\ prostate\\:\\ 0\\.004498367001933045\ \(0\)\
\-\ fracture\\:\\ 0\\.004465955064960909\ \(0\)\
\-\ fragments\\:\\ 0\\.004431826563045405\ \(0\)\
\-\ duty\\:\\ 0\\.004419038252999908\ \(0\)\
\-\ population\\:\\ 0\\.004419038252999908\ \(0\)\
\-\ cartilage\\:\\ 0\\.004406412855797301\ \(0\)\
\-\ isolated\\:\\ 0\\.004406412855797301\ \(0\)\
\-\ hands\\:\\ 0\\.0043816345582696325\ \(0\)\
\-\ pulse\\:\\ 0\\.004369473911498756\ \(0\)\
\-\ m\\:\\ 0\\.004369473911498756\ \(0\)\
\-\ 5th\\:\\ 0\\.004357460670138652\ \(0\)\
\-\ wnl\\:\\ 0\\.00434559130339265\ \(0\)\
\-\ possibly\\:\\ 0\\.004333862405823768\ \(0\)\
\-\ feet\\:\\ 0\\.004333862405823768\ \(0\)\
\-\ factor\\:\\ 0\\.004322270691489584\ \(0\)\
\-\ alcohol\\:\\ 0\\.004266262554459513\ \(0\)\
\-\ lobulated\\:\\ 0\\.004255430968203625\ \(0\)\
\-\ 36\\:\\ 0\\.004244716482471003\ \(0\)\
\-\ serial\\:\\ 0\\.004223628872513338\ \(0\)\
\-\ develop\\:\\ 0\\.004223628872513338\ \(0\)\
\-\ symptoms\\:\\ 0\\.0042213230463788685\ \(0\)\
\-\ concern\\:\\ 0\\.004213250973735047\ \(0\)\
\-\ pmh\\:\\ 0\\.004213250973735047\ \(0\)\
\-\ progression\\:\\ 0\\.004213250973735047\ \(0\)\
\-\ series\\:\\ 0\\.004213250973735047\ \(0\)\
\-\ different\\:\\ 0\\.004192815604852256\ \(0\)\
\-\ earlier\\:\\ 0\\.004182753789724389\ \(0\)\
\-\ skeletal\\:\\ 0\\.004182753789724389\ \(0\)\
\-\ expansion\\:\\ 0\\.004172793100077707\ \(0\)\
\-\ physical\\:\\ 0\\.004155610048723961\ \(0\)\
\-\ higher\\:\\ 0\\.004153167106721731\ \(0\)\
\-\ close\\:\\ 0\\.004133922224801909\ \(0\)\
\-\ women\\:\\ 0\\.004115043934444431\ \(0\)\
\-\ larger\\:\\ 0\\.004078333060628426\ \(0\)\
\-\ potential\\:\\ 0\\.004078333060628426\ \(0\)\
\-\ lead\\:\\ 0\\.004060475275194651\ \(0\)\
\-\ vitals\\:\\ 0\\.004051665614721663\ \(0\)\
\-\ systemic\\:\\ 0\\.004051665614721663\ \(0\)\
\-\ leading\\:\\ 0\\.004051665614721663\ \(0\)\
\-\ become\\:\\ 0\\.00403427779544425\ \(0\)\
\-\ american\\:\\ 0\\.00403427779544425\ \(0\)\
\-\ painful\\:\\ 0\\.00402569696021817\ \(0\)\
\-\ our\\:\\ 0\\.00402569696021817\ \(0\)\
\-\ states\\:\\ 0\\.003983873021179145\ \(0\)\
\-\ current\\:\\ 0\\.0039676254396373446\ \(0\)\
\-\ injuries\\:\\ 0\\.003951639927318332\ \(0\)\
\-\ though\\:\\ 0\\.003928134945537048\ \(0\)\
\-\ was\\:\\ 0\\.003917849443860007\ \(0\)\
\-\ 35\\:\\ 0\\.0038976377615263895\ \(0\)\
\-\ sensation\\:\\ 0\\.003890157874870906\ \(0\)\
\-\ lucency\\:\\ 0\\.003890157874870906\ \(0\)\
\-\ displaced\\:\\ 0\\.003890157874870906\ \(0\)\
\-\ radial\\:\\ 0\\.0038827340178548926\ \(0\)\
\-\ ovarian\\:\\ 0\\.0038753653573122583\ \(0\)\
\-\ mother\\:\\ 0\\.0038680510785237326\ \(0\)\
\-\ l\\:\\ 0\\.0038607903846762867\ \(0\)\
\-\ those\\:\\ 0\\.003853582496342214\ \(0\)\
\-\ r\\:\\ 0\\.003846426650977013\ \(0\)\
\-\ can\\:\\ 0\\.003841867893893101\ \(0\)\
\-\ incidentally\\:\\ 0\\.0038393221024352765\ \(0\)\
\-\ overlying\\:\\ 0\\.0038322681205037955\ \(0\)\
\-\ 21\\:\\ 0\\.0038322681205037955\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.0038183090125932517\ \(0\)\
\-\ lytic\\:\\ 0\\.003790967132990844\ \(0\)\
\-\ clinic\\:\\ 0\\.0037842479189319953\ \(0\)\
\-\ from\\:\\ 0\\.0037654183740957747\ \(0\)\
\-\ infarct\\:\\ 0\\.003757817545213302\ \(0\)\
\-\ exam\\:\\ 0\\.0037209790682845158\ \(0\)\
\-\ hernia\\:\\ 0\\.003706981772777672\ \(0\)\
\-\ their\\:\\ 0\\.003706981772777672\ \(0\)\
\-\ the\\:\\ 0\\.0036994357651118893\ \(0\)\
\-\ review\\:\\ 0\\.003670496170079242\ \(0\)\
\-\ near\\:\\ 0\\.0036645437180869607\ \(0\)\
\-\ femur\\:\\ 0\\.0036586268033332397\ \(0\)\
\-\ children\\:\\ 0\\.0036586268033332397\ \(0\)\
\-\ via\\:\\ 0\\.0036353061914301734\ \(0\)\
\-\ underlying\\:\\ 0\\.003629560782426877\ \(0\)\
\-\ for\\:\\ 0\\.0036130235314306993\ \(0\)\
\-\ osseous\\:\\ 0\\.0035957706819878523\ \(0\)\
\-\ and\\/or\\:\\ 0\\.003579298054400102\ \(0\)\
\-\ radiology\\:\\ 0\\.003579298054400102\ \(0\)\
\-\ limited\\:\\ 0\\.0035738674639495317\ \(0\)\
\-\ bones\\:\\ 0\\.0035738674639495317\ \(0\)\
\-\ defined\\:\\ 0\\.0035684664681442145\ \(0\)\
\-\ general\\:\\ 0\\.0035684664681442145\ \(0\)\
\-\ multiple\\:\\ 0\\.0035675044667577184\ \(0\)\
\-\ done\\:\\ 0\\.0035109205801811213\ \(0\)\
\-\ recommended\\:\\ 0\\.0035109205801811213\ \(0\)\
\-\ arising\\:\\ 0\\.0035058511047928453\ \(0\)\
\-\ appear\\:\\ 0\\.003466202606662321\ \(0\)\
\-\ presents\\:\\ 0\\.0034601472656252247\ \(0\)\
\-\ initially\\:\\ 0\\.0034469577247424974\ \(0\)\
\-\ tender\\:\\ 0\\.0034374736305738647\ \(0\)\
\-\ range\\:\\ 0\\.0034095540300122227\ \(0\)\
\-\ motion\\:\\ 0\\.003404976283871198\ \(0\)\
\-\ cells\\:\\ 0\\.0033958837404856265\ \(0\)\
\-\ repair\\:\\ 0\\.0033913685605690158\ \(0\)\
\-\ 15\\:\\ 0\\.0033779451461906636\ \(0\)\
\-\ symptomatic\\:\\ 0\\.003364701114662252\ \(0\)\
\-\ 24\\:\\ 0\\.0032928215863488102\ \(0\)\
\-\ previous\\:\\ 0\\.0032887514357515324\ \(0\)\
\-\ rare\\:\\ 0\\.0032887514357515324\ \(0\)\
\-\ malignancy\\:\\ 0\\.0032726359542135934\ \(0\)\
\-\ note\\:\\ 0\\.00326864769821783\ \(0\)\
\-\ skin\\:\\ 0\\.003252853255935558\ \(0\)\
\-\ second\\:\\ 0\\.003252853255935558\ \(0\)\
\-\ active\\:\\ 0\\.0032334577195687617\ \(0\)\
\-\ 50\\:\\ 0\\.0032220000164953464\ \(0\)\
\-\ radiographic\\:\\ 0\\.0032144344814556327\ \(0\)\
\-\ confirmed\\:\\ 0\\.003184736970353615\ \(0\)\
\-\ has\\:\\ 0\\.0031807729841313733\ \(0\)\
\-\ which\\:\\ 0\\.003161832680361841\ \(0\)\
\-\ calcifications\\:\\ 0\\.003148824335612242\ \(0\)\
\-\ breast\\:\\ 0\\.0031244380018142243\ \(0\)\
\-\ intact\\:\\ 0\\.0031107677122876277\ \(0\)\
\-\ since\\:\\ 0\\.0031107677122876277\ \(0\)\
\-\ pain\\:\\ 0\\.003102898416840638\ \(0\)\
\-\ reported\\:\\ 0\\.003087289247349665\ \(0\)\
\-\ risk\\:\\ 0\\.003067598262992157\ \(0\)\
\-\ portion\\:\\ 0\\.003067598262992157\ \(0\)\
\-\ 20\\:\\ 0\\.003045109252881086\ \(0\)\
\-\ obtained\\:\\ 0\\.0030107691781405765\ \(0\)\
\-\ palpable\\:\\ 0\\.0030016065833496437\ \(0\)\
\-\ typically\\:\\ 0\\.0029895200887076036\ \(0\)\
\-\ presentation\\:\\ 0\\.0029171463176323907\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0028628269553975095\ \(0\)\
\-\ areas\\:\\ 0\\.0028496998723945162\ \(0\)\
\-\ size\\:\\ 0\\.0028393219736162255\ \(0\)\
\-\ palpation\\:\\ 0\\.0028265005751715085\ \(0\)\
\-\ swelling\\:\\ 0\\.002821418101071489\ \(0\)\
\-\ joint\\:\\ 0\\.002738780232945571\ \(0\)\
\-\ finding\\:\\ 0\\.0027294960406724295\ \(0\)\
\-\ several\\:\\ 0\\.002722589529952812\ \(0\)\
\-\ often\\:\\ 0\\.002702154161070022\ \(0\)\
\-\ injury\\:\\ 0\\.002699909357669772\ \(0\)\
\-\ between\\:\\ 0\\.0026843365076553456\ \(0\)\
\-\ radiographs\\:\\ 0\\.0026821316562954736\ \(0\)\
\-\ known\\:\\ 0\\.002679931699171278\ \(0\)\
\-\ area\\:\\ 0\\.0026777366146028417\ \(0\)\
\-\ of\\:\\ 0\\.002655686242174166\ \(0\)\
\-\ such\\:\\ 0\\.0026475052426569398\ \(0\)\
\-\ image\\:\\ 0\\.002645380739640833\ \(0\)\
\-\ examination\\:\\ 0\\.0026327284791621062\ \(0\)\
\-\ clinical\\:\\ 0\\.0026058570862893997\ \(0\)\
\-\ some\\:\\ 0\\.0025717822139412873\ \(0\)\
\-\ usually\\:\\ 0\\.0025717822139412873\ \(0\)\
\-\ as\\:\\ 0\\.002562096146470025\ \(0\)\
\-\ month\\:\\ 0\\.002540747810506055\ \(0\)\
\-\ there\\:\\ 0\\.0025207444132110774\ \(0\)\
\-\ \\.\\:\\ 0\\.0024979851961462692\ \(0\)\
\-\ 5\\:\\ 0\\.0024778596852766733\ \(0\)\
\-\ loss\\:\\ 0\\.002458339120384975\ \(0\)\
\-\ not\\:\\ 0\\.0024476088637104764\ \(0\)\
\-\ changes\\:\\ 0\\.002427203147903925\ \(0\)\
\-\ appearance\\:\\ 0\\.0024221076082602986\ \(0\)\
\-\ through\\:\\ 0\\.0024053092353031403\ \(0\)\
\-\ secondary\\:\\ 0\\.002367720482169284\ \(0\)\
\-\ high\\:\\ 0\\.0023176868791643366\ \(0\)\
\-\ if\\:\\ 0\\.00229806088580836\ \(0\)\
\-\ therapy\\:\\ 0\\.0022642624343316283\ \(0\)\
\-\ due\\:\\ 0\\.00225993771353106\ \(0\)\
\-\ common\\:\\ 0\\.002216320328995438\ \(0\)\
\-\ patients\\:\\ 0\\.002191847967657112\ \(0\)\
\-\ both\\:\\ 0\\.0021627353723351053\ \(0\)\
\-\ abdominal\\:\\ 0\\.0021168674312409467\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0020814024158888177\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0020413771080101516\ \(0\)\
\-\ noted\\:\\ 0\\.0020073549935109947\ \(0\)\
\-\ tissue\\:\\ 0\\.0020073549935109947\ \(0\)\
\-\ man\\:\\ 0\\.00200290569186323\ \(0\)\
\-\ without\\:\\ 0\\.001994066567252884\ \(0\)\
\-\ imaging\\:\\ 0\\.0019842158815219055\ \(0\)\
\-\ a\\:\\ 0\\.001965311208219035\ \(0\)\
\-\ most\\:\\ 0\\.0019552379997305014\ \(0\)\
\-\ were\\:\\ 0\\.001922979521000913\ \(0\)\
\-\ well\\:\\ 0\\.0019158384073029247\ \(0\)\
\-\ it\\:\\ 0\\.001903714949983168\ \(0\)\
\-\ case\\:\\ 0\\.0018528289721182068\ \(0\)\
\-\ surgical\\:\\ 0\\.0017801999705168022\ \(0\)\
\-\ lesion\\:\\ 0\\.0017250299563929183\ \(0\)\
\-\ is\\:\\ 0\\.0016718259020358543\ \(0\)\
\-\ also\\:\\ 0\\.0016695932543807248\ \(0\)\
\-\ with\\:\\ 0\\.0016234474383136335\ \(0\)\
\-\ on\\:\\ 0\\.001434868210833356\ \(0\)\
\-\ by\\:\\ 0\\.0014101792896381315\ \(0\)\
\-\ disease\\:\\ 0\\.0013842790299461885\ \(0\)\
\-\ normal\\:\\ 0\\.0013276634832498524\ \(0\)\
\-\ an\\:\\ 0\\.0011711247416102376\ \(0\)\
\-\ history\\:\\ 0\\.0011696873515431947\ \(0\)\
\-\ at\\:\\ 0\\.0011474362267905184\ \(0\)\
\-\ patient\\:\\ 0\\.0008489513685989969\ \(0\)\
